摘要 |
<p>PCT No. PCT/FR95/00819 Sec. 371 Date Mar. 25, 1997 Sec. 102(e) Date Mar. 25, 1997 PCT Filed Jun. 20, 1995 PCT Pub. No. WO96/01117 PCT Pub. Date Jan. 18, 1996The invention relates to the use of metronidazole, or preferably of a combination of metronidazole and clindamycin, as active principle for the manufacture of pharmaceutical compositions, more particularly dermatological compositions, intended for an anti-inflammatory treatment by the topical route.</p> |